Zafgen

Dedicated to the treatment of obesity.

• 
• 
• 
• 
• 
• 
• 

News

June 26, 2010
Zafgen Presents Data on a New Class of Medicines to Treat Obesity at the American Diabetes Association Annual Meeting

October 26, 2009
Zafgen, Inc. to Present at Upcoming Conferences

June 9, 2009
Zafgen Scientific Advisory Board Member Randy Seeley, Ph.D., Receives Outstanding Scientific Achievement Award at American Diabetes Association Annual Meeting

June 8, 2009
Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions

May 14, 2009
Zafgen, Inc. Announces Participation at BIO 2009 International Convention

May 5, 2009
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development

April 27, 2009
Zafgen, Inc. to Present at Xconomy Forum

March 25, 2009
Zafgen, Inc. to Present at Upcoming Conferences

January 29, 2009
Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity

October 16, 2008
Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference

September 9, 2008
Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer